1-4 of 4
Katherine Ruffner, MD
Close
Sort by
Journal Articles

131 I-Anti-CD45 Antibody Plus Fludarabine, Low-Dose Total Body Irradiation and Peripheral Blood Stem Cell Infusion for Elderly Patients with Advanced Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS).

John M. Pagel, MD, PhD, Frederick R. Appelbaum, MD, Brenda M. Sandmaier, MD, Joseph G. Rajendran, MD, Ted Gooley, PhD, Darrell R. Fisher, PhD, Eneida Nemecek, MD, Ajay K. Gopal, MD, Michael B. Maris, MD, Katherine Ruffner, MD, Dana C. Matthews, MD, H. Joachim Deeg, MD, David G. Maloney, MD, PhD, Paul J. Martin, MD, Rainer Storb, MD
Journal: Blood
Blood (2005) 106 (11): 397.
https://doi.org/10.1182/blood.V106.11.397.397
Published: 2005
Journal Articles

Predictive Value for Engraftment and Survival of Total Nucleated Cell Dose (TNC) as Compared to CD34 + Cell Dose after Autologous and Allogeneic Bone Marrow Transplant (BMT) for Hematologic Malignancies.

Adetola A. Kassim, MD, Shin Mineishi, MD, Madan Jagasia, MD, Madhuri Vurisikala, MD, Stacey Goodman, MD, John P. Greer, MD, Wichai Chinratanalab, MD, Katherine Ruffner, MD, David S. Morgan, MD, Richard S. Stein, MD, Stephen Brandt, MD, Friedrich G. Schuening, MD
Journal: Blood
Blood (2004) 104 (11): 5055.
https://doi.org/10.1182/blood.V104.11.5055.5055
Published: 2004
Journal Articles

131 I-Anti-CD45 Antibody Plus Busulfan/Cyclophosphamide in Matched Related Transplants for Acute Myeloid Leukemia in First Remission.

John M. Pagel, MD, PhD, Frederick R. Appelbaum, MD, Janet F. Eary, MD, Joseph G. Rajendran, MD, Darrell R. Fisher, PhD, Ted Gooley, PhD, Eneida Nemecek, MD, Katherine Ruffner, MD, Eileen Sickle, RN, Larry Durack, CNMT, Jeanette Carreras, MPH, Mary M. Horowitz, MD, MS, Ajay K. Gopal, MD, Oliver W. Press, MD, PhD, Paul J. Martin, MD, Irwin D. Bernstein, MD, Dana C. Matthews, MD
Journal: Blood
Blood (2004) 104 (11): 813.
https://doi.org/10.1182/blood.V104.11.813.813
Published: 2004
Journal Articles

Post-Transplant Positron Emission Tomography Using Fluorine 18-Fluoro-Deoxyglucose ([ 18 F]FDG-PET) Correlates with Outcome in Patients with Aggressive Non-Hodgkin’s Lymphoma Undergoing High Dose Chemotherapy Followed by Autologous Stem-Cell Transplantation (HDC/ASCT).

Adetola A. Kassim, MD, Shin Mineishi, MD, John P. Greer, MD, Natalie McVay, Tatsuki Koyama, PhD, Wichai Chinratanalab, MD, Stephen J. Brandt, MD, Madan Jagasia, MD, Katherine Ruffner, MD, Friedrich G. Schuening, MD, Richard S. Stein, MD, Madhuri Vusirikala, MD, Stacey Goodman, MD, David S. Morgan, MD
Journal: Blood
Blood (2004) 104 (11): 906.
https://doi.org/10.1182/blood.V104.11.906.906
Published: 2004